Table 3:
Survival and secondary outcomes post DCD HT vs. DBD HT
| Unmatched cohort | Matched Cohort | |||||
|---|---|---|---|---|---|---|
| DCD (n=425) |
DBD (n=9977) |
P-value | DCD (n=425) |
DBD (n=850) |
p-value | |
| Survival % (95% CI) | 0.72 HR=0.937 (0.655–1.34) |
0.22 HR=1.3 (0.84–2) |
||||
| 6mo | 94 (9196) | 92 (92–93) | 94 (91–96) | 94 (92–96) | ||
| 12mo | 92 (8995) | 90 (90–91) | 92 (89–95) | 93 (91–95) | ||
| 18mo | 90 (8594) | 88 (87–88) | 90 (85–94) | 91 (89–93) | ||
| 24mo | 80 (71–91) | 86 (85–86) | 80 (71–91) | 88 (86–91) | ||
| Stroke, n (%) | 14 (3.3%) | 385 (3.9%) | 0.264 | 14 (3.3%) | 26 (3.1%) | 0.465 |
| Acute Rejection episodes, n (%) | 82 (19%) | 1752 (18%) | 0.383 | 82 (19%) | 152 (18%) | 0.578 |
| Dialysis Requirement, n (%) | 73 (17%) | 1678 (16.8%) | 0.892 | 73 (17%) | 111 (13%) | 0.059 |
| Hospital Length of Stay, median [IQR] | 16 [12–24] | 17 [12–26] | 0.097 | 16 [12–24] | 16 [12–24] | 0.894 |
| Cause of Death, n (%) | ||||||
| Cardiac | 6 (1.4%) | 244 (2.4%) | 0.172 | 6 (1.4%) | 21 (2.5%) | 0.215 |
| Pulmonary | 3 (0.7%) | 74 (0.7%) | 0.932 | 3 (0.7%) | 7 (0.8%) | 0.822 |
| Infection | 11 (2.6%) | 278 (2.8%) | 0.807 | 11 (2.6%) | 21 (2.5%) | 0.899 |
| CVA | 1 (0.2%) | 90 (0.9%) | 0.148 | 1 (0.2%) | 3 (0.4%) | 0.723 |
| Other | 10 (2.4%) | 365 (3.7%) | 0.157 | 10 (2.4%) | 22 (2.6%) | 0.800 |